Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · IEX Real-Time Price · USD

3.370

-0.230 (-6.39%)

At close: Jul 2, 2024, 4:00 PM

3.460

+0.090 (2.67%)

After-hours: Jul 2, 2024, 7:45 PM EDT

Adaptive Biotechnologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Net Income	-225.25	-200.19	-207.28	-146.23	-69.57	Upgrade
Depreciation & Amortization	29.15	28.15	20.98	11.74	7.79	Upgrade
Share-Based Compensation	62.91	55.48	43.25	24.76	13.12	Upgrade
Other Operating Activities	-23.13	-67.38	-49.68	-39.96	253.1	Upgrade
Operating Cash Flow	-156.32	-183.95	-192.73	-149.68	205.4	Upgrade
Capital Expenditures	-10.7	-16.35	-61.75	-18.8	-11.2	Upgrade
Change in Investments	140.34	19.25	242.96	-98.24	-470.5	Upgrade
Investing Cash Flow	129.65	2.91	181.21	-117.04	-481.7	Upgrade
Share Issuance / Repurchase	2.25	7.89	26.72	293.91	324.91	Upgrade
Debt Issued / Paid	0	124.38	0	0	0	Upgrade
Other Financing Activities	-	-	0.43	-0.32	-5	Upgrade
Financing Cash Flow	2.25	132.27	27.15	293.59	319.92	Upgrade
Net Cash Flow	-24.43	-48.78	15.63	26.86	43.62	Upgrade
Free Cash Flow	-167.02	-200.29	-254.47	-168.49	194.2	Upgrade
Free Cash Flow Margin	-98.09%	-108.09%	-164.87%	-171.26%	228.28%	Upgrade
Free Cash Flow Per Share	-1.16	-1.41	-1.81	-1.28	2.81	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).